NB 001 may reduce symptom duration in patients with herpes labialis

Source: Inpharma, Volume 1, Number 1498, 2005-07-30 , pp. 7-7(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Drug-delivery-systems; Herpes-labialis, treatment; NB-001, therapeutic use; Research-and-development; Trial-result-clinical

Document Type: Short communication

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$34.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A